Inflammatory properties of peptidoglycan are decreased after degradation by human N-acetylmuramyl-L-alanine amidase

European Cytokine Network

Volumn 8, Issue 4, 1997, Pages 375-381

  Hoijer, Maarten A ^a   Melief, Marie José ^a   Debets, Reno ^a   Hazenberg, Maarten P ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

N acetylmuramyl L alanine amidase; Peptidoglycan

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; LYSOZYME; N ACETYLMURAMOYLALANINE AMIDASE; PEPTIDOGLYCAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; BACTERIAL CELL WALL; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MOUSE; NONHUMAN; NORMAL HUMAN; PROTEIN DEGRADATION; RAT;

ANIMALS; CARBOHYDRATE SEQUENCE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MURAMIDASE; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; PEPTIDOGLYCAN; RATS; RATS, INBRED LEW; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031435146     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. 14C-labeled immunoadjuvant peptidoglycan monomer. II. In vitro studies. Biochim. Biophys. Acta 678: 12.
2. Mollner S, Braun V. 1984. Murein hydrolase (N-acetylmuramyl-L-alanine amidase) in human serum. Arch. Microbiol. 140: 171.
3. Valinger Z. 1982. Partial purification and characterization of N-acetylmuramyl-L-alanine amidase from human and mouse serum. Biochim. Biophys. Acta 701: 63.
4. Vanderwinkel E, De Vlieghere M, De Pauw P, Cattalini N, Ledoux V, Gigot D, ten Have J P. 1990. Purification and characterization of N-acetylmuramyl-L-alanine amidase from human serum. Biochem. Biophys. Acta 1039: 331.
5. Hoijer M A, Melief M J, Keck W, Hazenberg M P. 1996. Purification and characterization of N-acetylmuramyl-L-alanine amidase from human plasma using monoclonal antibodies. Biochim. Biophys. Acta 1289: 57.
6. Hoijer M A, Mclief M J, Calafat J, Roos D, van den Beemd M W M, van Dongen J J M, Hazenberg M P. 1997. Expression and intracellular localization of the human N-acetylmuramyl-L-alanine amidase. A bacterial cell wall degrading enzyme. Blood 90: 1246.
7. Johannsen L, Toth L A, Rosenthal R S, Opp M R, Obál F Jr, Cady A B, Krueger J M. 1990. Somnogenic, pyrogenic, and hematologic effects of bacterial peptidoglycan. Am. J. Physiol. 258: R182.
8. Johannsen L, Wecke J, Obál F Jr, Krueger J M. 1991. Macrophages produce somnogenic and pyrogenic muramyl peptides during digestion of staphylococci. Am. J. Physiol. 259: R126.
9. Martin S A, Karnovsky J L, Krueger J M, Pappenheimer J R, Biemann K. 1984. Peptidoglycans as promoters of slow wave sleep. I. Structure of the sleep-promoting factor isolated from human urine. J. Biol. Chem. 259: 7514.
10. Wilkinson B J, Kim Y, Peterson P K. 1981. Factors affecting complement activation of Staphylococcus aureus cell walls, their components, and mutants altered in teichoic acid. Infect. Immun. 32: 216.
11. Johannsen L. Biological properties of bacterial peptidoglycan. 1993. (Review) APMIS 101: 337.
12. Severijnen A J, Kool J, Swaak A J G, Hazenberg M P. 1990. Intestinal flora of patients with rheumatoid arthritis: induction of chronic arthritis in rats by cell wall fragments from isolated Eubacterium aerofaciens strains. Br. J. Rheumatol. 29: 433.
13. Severijnen A J, van Kleet R, Hazenberg M P, van de Merwe J P. 1989. Cell wall fragments from major residents of the human intestinal flora induce chronic arthritis in rats. J. Rheumatol. 16: 1061.
14. Severijnen A J, van Kleef R, Hazenberg M P, van de Merwe J P. 1990. Chronic arthritis induced in rats by cell wall fragments of Eubacterium species from the human intestinal flora. Infect. Immun. 58: 523.
15. Kool J, Severijnen A J, Klasen I S, Gerrits-Boeye M Y, Hazenberg M P. 1992. Influence of decontamination on induction of arthritis in Lewis rats by cell wall fragments of Eubacterium aerofaciens. Arthropathic properties of indigenous anaerobic bacteria. Ann. Rheum. Dis. 51: 510.
16. Gupta D, Jin Y, Dziarski R. 1995. Peptidoglycan induces transcription and secretion of TNF-α and activation of lyn, extracellular signal-regulated kinase, and rsk signal transduction proteins in mouse macrophages. J. Immunol. 155: 2620.
17. Mattsson E, Verhage L, Rollof J, Fleer A, Verhoef J, van Dijk H. 1993. Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumor necrosis factor-α, interleukin-1β and interleukin-6. FEMS Immunol. Med. Microbiol. 7: 281.
18. Heumann D, Barras C, Severin A, Glauser M P, Tomasz A. 1995. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect. Immun. 62: 2715.
19. Hoijer M A, Melief M J, van Helden-Meeuwsen C G, Eulderink F, Hazenberg M P. 1995. Detection of muramic acid in carbohydrate fraction of human spleen. Infect Immun. 63: 1652.
20. Melief M J, Hoijer M A, van Paassen H C, Hazenberg M P. 1995. Presence of bacterial flora-derived antigen in synovial tissue macrophages and dendritic cells. Brit. J. Rheum. 34: 1112.
21. Lehtonen L, Eerola E, Oksman P, Toivanen P. 1995. Muramic acid in peripheral blood leukocytes of healthy human subjects. J. Infect. Dis. 171: 1060.
22. Fox A, Fox K, Christensson B, Harrelson D, Krahmer M. 1996. Absolute identification of muramic acid at trace levels in human septic synovial fluids in vivo and absence in aseptic fluids. Infec. Immun. 64: 3911.
23. Jollès P, Jollès J. 1984. What's new in lysozyme research? Mol. Cell Biochem. 63: 165.
24. Striker R, Kline M E, Haak R A, Rest R F, Rosenthal R S. 1987. Degradation of gonococcal peptidoglycan by granule extract from human neutrophils: demonstration of N-acetylglucosaminidase activity that utilizes peptidoglycan substrates. Infect. Immun. 55: 2579.
25. Walker P G, Woollen M E, Pugh D. 1960. N-acetyl-β-glucosaminidase activity in serum during pregnancy. J. Clin. Path. 13: 353.
26. Beutler B, Cerami A. 1987. Cachectin: more than a tumor necrosis factor. (Review) N. Engl. J. Med. 316: 379.
27. Chen P A, Toribara T Y, Warner H. 1956. Microdetermination of phosphorus. Annal. Chem. 28: 1756.
28. Hadzija O. 1974. A simple method for the quantitative determination of muramic acid. Annal. Biochem. 50: 512.
29. Hazenberg M P, de Visser H. 1992. Assay for N-acetylmuramyl-L-alanine amidase in serum by determination of muramic acid released from the peptidoglycan of Brevibacterium divaricatum. Eur. J. Clin. Chem. Clin. Biochem. 30: 141.
30. Dische Z, Shettles L B. 1948. A specific color reaction of methylpentoses and a spectrophotometric micromethod for their determination. J. Biol. Chem. 175: 595.
31. Espevik T, Nissen-Meyer J. 1986. A highly sensitive cell line. WEH1 164 clone 13 for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95: 99.
32. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55.
33. Hopkins S J, Humphreys M. 1989. Simple, sensitive and specific bioassay of interleukin-1. J. Immunol. Methods 120: 271.
34. Debets R, van Joost Th, Benner R, Prens E P. 1993. Psoriatic epidermal cells release elevated levels of immunoreactive and biologically active interleukins-1 and -6: modulation of corticosteroid treatment. In: From molecular biology to therapeutics. Bernard B A, Shroot B., eds. Pharmacol Skin, Shroot B, Schaefer H, eds. S. Karger. Basel. 5: 158.
35. Aarden L A, de Groot E R, Schaap O L, Lansdorp P M. 1987. Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 17: 1411.
36. Fox A, Brown R R, Anderle S K, Chetty C, Cromartie W J, Gooder H, Schwab J H. 1982. Arthropathic properties related to the molecular weight of peptidoglycan-polysaccharide polymers of streptococcal cell walls. Infect. Immun. 35: 1003.
37. Kool J, Severijnen A J, Gerrits-Boeye M Y, Hazenberg M P. 1992. Arthritogenicity of Eubacterium species in the adjuvant arthritis model. J. Rheumatol. 19: 1000.
38. Kohashi O, Pearson C M, Watanabe Y, Kotani S, Koga T. 1976. Structural requirements for arthritogenicity of peptidoglycans from Staphylococcus aureus and Lactobacillus plantarum and analogous synthetic compounds. J. Immunol. 116: 1635.
39. Kohashi O, Tanaka A, Kotani A, Shiba T, Kusumoto S, Yokogawa K, Kawata S, Ozawa A. 1980. Arthritis-inducing ability of a synthetic adjuvant, N-acetylmuramyl peptides and bacterial disaccharide peptides related to different oil vehicles and their composition. Infect. Immun. 29: 70.
40. Lehtonen L, Kortekangas P, Oksman P, Eerola E, Aro H, Toivanen A. 1994. Synovial fluid muramic acid in acute inflammatory arthritis. Brit. J. Rheumatol. 33: 1127.
41. Lehman T J A, Allen J B, Plotz P H, Wilder R L. 1985. Bacterial cell wall composition, lysozyme resistance, and the induction of chronic arthritis in rats. Rheumatol. Int. 5: 163.
42. Vanderwinkel E, De Pauw P, Philipp D, ten Have J P, Bainter K. 1995. The human and mammalian N-acetylmuramyl-L-alanine amidase: distribution, action on different bacterial peptidoglycans, and comparison with the human lysozyme activities. Biochem. Mol. Med. 54: 26.